Hypoxia Inhibits Osteogenesis in Human Mesenchymal Stem Cells through Direct Regulation of RUNX2 by TWIST
Open Access
- 9 September 2011
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (9) , e23965
Abstract
Bone loss induced by hypoxia is associated with various pathophysiological conditions, however, little is known about the effects of hypoxia and related signaling pathways on osteoblast differentiation and bone formation. Because bone marrow-derived mesenchymal stem cells (MSCs) survive under hypoxic conditions and readily differentiate into osteoblasts by standard induction protocols, they are a good in vitro model to study the effects of hypoxia on osteoblast differentiation. Using human MSCs, we discovered TWIST, a downstream target of HIF-1α, was induced under hypoxia and acted as a transcription repressor of RUNX2 through binding to the E-box located on the promoter of type 1 RUNX2. Suppression of type 1 RUNX2 by TWIST under hypoxia further inhibited the expression of BMP2, type 2 RUNX2 and downstream targets of RUNX2 in MSCs. Our findings point to the important role of hypoxia-mediated signalling in osteogenic differentiation in MSCs through direct regulation of RUNX2 by TWIST, and provide a method for modifying MSC osteogenesis upon application of these cells in fracture healing and bone reconstruction.Keywords
This publication has 34 references indexed in Scilit:
- Osteoclast size is controlled by Fra-2 through LIF/LIF-receptor signalling and hypoxiaNature, 2008
- Hypoxia and Hypoxia-Inducible Factor-1 Expression Enhance Osteolytic Bone Metastases of Breast CancerCancer Research, 2007
- Bone mineral decrease in the leg with unilateral chronic occlusive arterial disease.2003
- Role of Vascular Factors in OsteoporosisThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2003
- Analysis of Type-I and Type-II RUNX2 Protein Expression in OsteoblastsBiochemical and Biophysical Research Communications, 2001
- Hypoxia-inducible factor 1: master regulator of O2 homeostasisCurrent Opinion in Genetics & Development, 1998
- Osf2/Cbfa1: A Transcriptional Activator of Osteoblast DifferentiationCell, 1997
- Targeted Disruption of Results in a Complete Lack of Bone Formation owing to Maturational Arrest of OsteoblastsCell, 1997
- Bone Mineral Density and Blood Flow to the Lower Extremities: The Study of Osteoporotic FracturesJournal of Bone and Mineral Research, 1997
- Abnormal bone growth and selective translational regulation in basic fibroblast growth factor (FGF-2) transgenic mice.Molecular Biology of the Cell, 1995